Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
25 Cards in this Set
- Front
- Back
Initial stage of shock
|
This stage is present when the clients baseling MAP is decrease by less that 10 mm Hg. During this stage, compensatroy mechanisms are so effective at returning MAP to normal levels that oxygenated blood flow to all vital organs is maintained.
Increased sympathetic stimulation(Mild vasoconstriction, and increase in heart rate) |
|
Nonprogressive Stage of shock
|
This stage occurs when MAP decreses 10-15 mm Hg below baseline.
A.Continued sympathetic stimulation(moderate vasocontriction, Increased heartrated, decreased pulse pressure) B. Chemical compensation(Renin, aldosteron and antidiuretic hormone scretion AEB increased vasocontriction, decreased urine output, stimulation of the thirst reflex) C. Some anaerobic metabolism in nonvital organs(mild acidosis, mild hyperkalemia) |
|
Progressive Stage of shock
|
Decrease in MAP of >20 mm Hg from baseline
A. Anoxia of nonvital organs B. Hypoxia of vital organs C. Overall metabolism is anaerobic(moderate acidois, moderate hyperkalemia, tissue ischemia) |
|
Refractory Stage of shock
|
A. Sever tissue hypoxia with ischemia and necrosis
b. Release of myocardial depressant factor from the pancreas c. buildup of toxic metabolites d. Multiple organ dysfunction syndrome e. Death |
|
Description of Septic Shock
|
Septic shock occurs when large amounts of toxins and endotoxins produced by bacteria are released into the blood, causing a whold body inflammotory reaction
|
|
Causes
|
any pathogenic organism
gram negative bacteria |
|
Complications
|
Disseminted intravascular coagulation
Renal failure heart failure GI ulcers abnormal liver function Death |
|
Assessment(History)
|
A. Assess age, ask about recent illness, trauma, invasive procedures, or chronic conditions, that may lead to sepsis
B. Assess for drug use in the past week, some drugs may cause changes that result in septic shock such drugs as: aspirin and aspirin containing drugs antibotics, and cancer therapy drugs |
|
Physical Assessment
|
Manifestations of the first phase are unique to septic shock and are often opposite from those seen with all other types of shock
|
|
Cardiovascular Changes
|
cardiac output increases during the first phase called hyperdynamic
also tachycardia, increased stroke volume, and normal to elevated systolic BP, and a normal CVP |
|
Respiratory Changes
|
HYPERDYNAMIC STAGE: respiratory rate and depth are increased, leading to respiratory alkalosis
hYPODYNAMIC STAGE: Acute respiratory distress may occur |
|
Psychosocial assessment
|
indicator that clients may be in the beginning of septic shock os a change in affect of behavior. Compare with how they acted earlier in the day, if possible.
|
|
Skin Changes
|
HYPERDYNAMIC STAGE:
No change hYPODYNAMIC STAGE: skinis cool, clammy, and pallor or cyanosis is present |
|
Laboratory assessment
|
Presence of bacteria in the blood
Obtain specimens of urine, blodd, sputum and any drainage for culture per DR. order Abnormal findings with septic shock is changes in WBS count the differential leuckocyte count may show a left shift Changes in H&H levels are usually not present until late in SS at that point fibrinogen levels and platelet count are low also. Activated protein C is reduced |
|
Expected outcomes
|
ABG's within normal range
Maintenance of urine output of at lease 20mL/hr Maintenance of MAP within 10mm hg of baseline absence of multiple organ dysfunction syndrome states measures to reduce risk for sepsis |
|
Interventions
|
-Ensure patent airway
-Start or KVO IV -Administer Oxygen -Obtain specimens of blood, urine, wound drainage, and sputum for culture -Increase IV fluid rate -Use aseptic technique -Handle client gently -Examine client for overt bleeding -Elevate clients feet, keeping head flat or at 30 degree angle -Take VS every 5 minutes until stable -Administer medications as prescribed ( heparin during phase 1, clotting factor platelets and plasma during phase 2) -DO NOT LEAVE CLIENT |
|
Drug therapy
|
A.Vasoconstrictors 1.Dopamine hydrochloride(Intropin, Revimine) 2. Epinephrine (Adrenalin) 3.Norepinephrine (Levophed) 4.Phenylephrine (Neo-synephrine)
B. Antibotics Drug therapy in the first phase is aimed at preventing coagulation, and second phase is aimed increasing the blood's ability to clot Doing experimental therapy by Giving clients antibodies |
|
Description of Cardiogenic Shock
|
A condition of diminished cardiac output that severly impairs tissue perfusion, the most lethal form of shock, sometimes called pump failure.
|
|
Causes
|
Direct Pump Failure
|
|
specific cause or risk factors
|
MI
cardiac arrest ventricular dysrhythmias(fibrillation, tachycardia) cardiac amyloidosis cardiomyopathies(viral, toxic) Myocardial degeneration |
|
Assessment Hx
|
Assess for disorders such as MI or cardiomyopathy that severely decreases left ventricular function, anginal pain
|
|
Physical findings
|
urine output less than 20 mL/hr
pale, cold clammy skin rapid shallow breathes rapid thready pulse MAP of less than 60mm Hg in adults Juggular vein distention severe anxiety decreased LOC pulmonary crackles |
|
Treatment
|
Intra aortic balloon pumo
Possible tube feedings or parental nutrition bed rest |
|
Medications
|
Vasopressors
Inotropics Vasoconstrictors analgesics;sedatives osmotic diuretics vasodilators oxygen |
|
Surgery
|
Possible heart transplant
possible ventricular device |